SpiroChem | News | SpiroChem | Tailor-Made Molecules

SpiroChem @ 54th International Conference on Medicinal Chemistry (RICT 2018)

Conferences

June 26, 2018

SpiroChem @ 54th International Conference on Medicinal Chemistry (RICT 2018)

SpiroChem @ 54th International Conference on Medicinal Chemistry Strasbourg, France July 4-6, 2018 SpiroChem is taking part in the 54th edition of the International Conference on Medicinal Chemistry (RICT 2018), organized by the French Medicinal Chemistry Society (Société de Chimie Thérapeutique - SCT) from July 4-6, 2018 in Strasbourg, France. The conference is devoted to “Interfacing Chemical Biology and Drug Discovery" while SpiroChem poster presentations will describe our results on new chemical spaces, namely: - the synthesis of new strained building blocks via...

SpiroChem sponsors DMCCB Basel Symposium 2018

Conferences

May 14, 2018

SpiroChem sponsors DMCCB Basel Symposium 2018

SpiroChem sponsors DMCCB Basel Symposium 2018 We are happy to announce that SpiroChem will be sponsoring the DMCCB Basel Symposium 2018, where the focus will be on «Novel Chemical Space and Tools for Chemical Biology, Medicinal and Agrochemistry». The SCS Division of Medicinal Chemistry & Chemical Biology The DMCCB comprises about 750 scientists interested in medicinal chemistry, chemical biology and related fields of research. It organizes scientific events such as the DMCCB Basel Symposiums, the Medicinal Chemistry & Chemical Biology session of the...

SpiroChem @ the Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry Conference

Conferences

March 28, 2018

SpiroChem @ the Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry Conference

SpiroChem @ the Cambridge Healthtech Institute's 13th Annual Drug Discovery Chemistry Conference San Diego, California - April 2-6, 2018 SpiroChem is taking part in the 13th Annual Drug Discovery Chemistry Conference organised by the Cambridge Healthtech Institute from April 2-6, 2018 in San Diego, California. The event, mainly aimed for medicinal chemists working in pharma and biotech, is particularly in line with the scope of SpiroChem’s expertise. Dr. Thomas Fessard, CEO of SpiroChem, who will be accompanied by Dr. Kristina Goncharenko; will be...

SpiroChem @ the 138th Annual Meeting of the Pharmaceutical Society of Japan (AMPSJ)

Conferences

March 27, 2018

SpiroChem @ the 138th Annual Meeting of the Pharmaceutical Society of Japan (AMPSJ)

SpiroChem @ the 138th Annual Meeting of the Pharmaceutical Society of Japan (AMPSJ) Kanazawa, Japan - 25-28 March, 2018 SpiroChem will be participating to the 138th Annual Meeting of the Pharmaceutical Society of Japan, held in Kanazawa from 25-28 March, 2018. Professor Erick M. Carreira, from ETH Zürich and Member of the Board of Directors at SpiroChem; will be delivering a lecture on the “Recent Developments in Strategies and Tactics Towards Complex Secondary Metabolites Including Human-Derived Natural Products” while our CEO, Dr...

Annual Summary 2017 - On track for ambitious growth path

Press Release

March 5, 2018

Annual Summary 2017 - On track for ambitious growth path

Annual Summary 2017On track for ambitious growth path 2017 has been an important year for SpiroChem as we transitioned from an early stage company to quickly becoming a key partner of the Life Sciences industry for complex medicinal chemistry. With a growing demand for our products and services, we relocated our company from Zürich to state-of-the-art laboratories in Basel in order to provide the infrastructure for our rapidly-growing business. To support this growth, we...